ACC 2018: The MANAGE Trial

Published: 11 Mar 2018

  • Views:

    Views Icon 432
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

The effect of dabigatran in patients suffering myocardial injury after non-cardiac surgery - ACC 2018


An expert peer-to-peer discussion on the latest data to come out of the MANAGE trial and its implications for clinical practice.


Sunday 11th March 2018 @ 11:45 EST

ACC.18 Congress, Orlando, FL


Discussants: Dr PJ Devereaux (Ontario, US) & Dr John Eikelboom (Ontario, US)


Dr PJ Devereaux, Director of Cardiology, McMaster University, Ontario

The focus of Prof Devereux’s clinic research is vascular complications around the time of surgery. He is undertaking several large international RCTs and observational studies addressing this issue. He has published more than 250 peer reviewed papers and over 50 book chapters and editorials.


Dr John Eikelboom, Associate Professor, Division of Hematology & Thromboembolism, McMaster University, Ontario

Dr Eikelboom’s current research focuses on variable response to antiplatelet therapy, antithrombotic therapy in atrial fibrillation, and mechanisms and prognosis of bleeding. He has published more than 150 peer-reviewed papers.

This discussion was funded by an unrestricted educational grant from Boehringer Ingelheim